MK-2828

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for MK-2828, covering 2026-02-12 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006) [Phase 1]